Not surprisingly, we observed high correlations between levels of the inflammation marker C-reactive protein and IL-6 (R = 0.67), IL-8 (R = 0.70), and IL-16 (R = 0.79) in sera of patients with HCC (n = 20, adj. This evidence concerns the gene IL16 and hepatocellular carcinoma.